• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Propanc Biopharma, Inc. - Common Stock (OP:PPCB)

10.40 UNCHANGED
Last Price Updated: 3:35 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 10.40
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 10.40
Today's Range 10.40 - 10.40
52wk Range 0.0002 - 11.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
September 17, 2025
Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP 
From Propanc Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 02, 2025
 
Via Benzinga

Performance

YTD
+2599900.0%
+2599900.0%
1 Month
N/A
N/A
3 Month
+73.3%
+73.3%
6 Month
+4.2%
+4.2%
1 Year
+2599900.0%
+2599900.0%

More News

Read More
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
September 02, 2025
From Propanc Biopharma, Inc.
Via GlobeNewswire
Why Propanc stock Is Tumbling In Premarket Today
August 19, 2025
Via Stocktwits
BioMedNewsBreaks — Propanc Biopharma, Inc. (NASDAQ: PPCB) Closes $4 Million Public Offering
August 29, 2025
Via Investor Brand Network
D. Boral Capital Acted as Lead Bookrunner to Propanc Biopharma, Inc. (Nasdaq:PPCB) in Connection with its $4,000,000 Uplisting
August 28, 2025
Via ACCESS Newswire
Propanc Biopharma Provides Shareholder Update
August 25, 2025
From Propanc Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 20, 2025
Via Benzinga
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
August 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 19, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 19, 2025
Via Benzinga
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
August 19, 2025
From Propanc Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 19, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 18, 2025
Via Benzinga
What's Going On With Propanc Shares Monday?
August 18, 2025
Via Benzinga
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
August 18, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 18, 2025
Via Benzinga
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
August 18, 2025
Via AB Newswire
Topics Artificial Intelligence
US Stocks Mixed; Riskified Shares Dip After Q2 Results
August 18, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 18, 2025
Via Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
August 18, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 15, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 15, 2025
Via Benzinga
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
August 14, 2025
From Propanc Biopharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Propanc Biopharma, Inc. - Common Stock publicly traded?
Yes, Propanc Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Propanc Biopharma, Inc. - Common Stock trade on?
Propanc Biopharma, Inc. - Common Stock trades on the OTC Traded
What is the ticker symbol for Propanc Biopharma, Inc. - Common Stock?
The ticker symbol for Propanc Biopharma, Inc. - Common Stock is PPCB on the OTC Traded
What is the current price of Propanc Biopharma, Inc. - Common Stock?
The current price of Propanc Biopharma, Inc. - Common Stock is 10.40
When was Propanc Biopharma, Inc. - Common Stock last traded?
The last trade of Propanc Biopharma, Inc. - Common Stock was at 08/14/25 03:35 PM ET
Recent Quotes
View More
Symbol Price Change (%)
GOOG  237.49
-4.72 (-1.95%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap